McKesson CLIA Waiver in Hand, Binx Health Targeting Retailers, Urgent Care Centers With STI Tests Premium Binx Health said that when it received FDA CLIA waiver, it already had a strategic partner for sales of its POC platform and chlamydia and gonorrhea tests. Binx Health Inks US Distribution Agreement With McKesson for Chlamydia, Gonorrhea Testing Platform Binx Health said the initial distribution of its platform will be to settings certified to perform moderate- or high-complexity diagnostic tests under CLIA. McKesson to Distribute Qiagen Syndromic Testing Platform in US McKesson will be the exclusive distributor of the QiaStat-Dx system in US hospitals with fewer than 200 beds and non-exclusive distributor for future expansion into retail pharmacy clinics. White House Announces Efforts to Accelerate Precision Medicine Initiative Dozens of government agencies, academic institutions, and a various public and private sector organizations have now committed to driving the initiative forward. Amid PAMA Implementation, Stakeholders Contemplate Coding to Facilitate Market-Based MDx Pricing Premium The coding requirements will be a particularly complicated aspect of implementing the new law which aims to move diagnostic pricing to a market-based system. Sep 18, 2013 McKesson to Distribute Atossa Specimen Kits for Breast Cancer Dx May 3, 2013 Theranostics Health to Launch HER Signaling Assay, Marking Firm's First Commercial Test Release Premium Mar 6, 2013 In Unexpected Collaboration, AMA, McKesson Partner to Clarify Molecular Diagnostic Claims Coding Premium Feb 26, 2013 McKesson, AMA Developing Reference Product for MDx Jan 30, 2013 Palmetto Loses Appeal to Remain JE CMS Contractor, but May Continue Running MolDx Premium Nov 7, 2012 UnitedHealthcare Sees Need for National Registry to Track Use, Set Coverage of Molecular Tests Premium Oct 17, 2012 Palmetto's Loss of Jurisdiction E Medicare Contract Raises Questions About Fate of MolDx Program Premium Sep 19, 2012 CMS Stance on Reimbursement of Multi-Analyte Algorithm Assays Raises Industry Concerns Premium Aug 31, 2012 Theranostics Looks for Med Fusion Deal to Aid in Clinical Validation, Payor Access Premium Apr 18, 2012 Harvard Pilgrim, Trustmark Join Other Payors Considering Outsourcing MDx Claims to Specialty Vendors Premium Mar 14, 2012 With MDx Usage and Costs on the Rise, UnitedHealthCare Urges Reimbursement Reform Premium Jan 4, 2012 Personalized Medicine in 2011: Some Successes, Slow Progress, Continued Economic Woes Premium Jan 4, 2012 AMA Threatens to File HIPAA Complaint Unless CMS Halts Program Requiring Z-Codes for MDx Tests Premium Nov 16, 2011 Palmetto Issuing 'Z-Codes' to Track Molecular Dx Utilization, Gather Data CPT Codes Can't Provide Premium Jul 8, 2011 McKesson Aims to Help Health Plans Navigate MDx, Genetic Testing Space Jun 14, 2011 New Health Plans Sign on for McKesson's Solutions for MDx, Genetic Testing May 11, 2011 Generation Health Tackles Slow Genetic Test Uptake by Unpacking CPT Codes, Planning Utility Studies Premium Aug 27, 2010 Movers & Shakers: Aug 27, 2010 Premium Mar 17, 2010 AMA's Molecular Pathology Workgroup Quietly Working on New CPT Coding System for Molecular Dxs Premium Nov 18, 2009 Payors Adopt McKesson's Automated InterQual Molecular Dx System to Avoid Inaccurate Coverage Decisions Premium Breaking News Sequencing Study Uncovers MERS-Related Coronavirus in Swiss Bats Angstrom Bio Raises $3M in Private Financing Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel The Scan CDC Calls Delta "Variant of Concern" CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern." From FDA to Venture Capital Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post. Consent Questions Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles. Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.